Please login to the form below

Not currently logged in
Email:
Password:

Amgen appoints ex US surgeon general

Steven Galson is also a former director of the FDA’s Center for Drug Evaluation and Research
Amgen Steven Galson

Amgen has named former US surgeon general Steven Galson as senior VP, global regulatory affairs and safety. He was previously VP, global regulatory affairs.

Galson has a distinguished career in public health, serving as acting surgeon general from 2007 to 2009, as well as assistant secretary for health during the transition from the administration of George W Bush to that of President Barack Obama.

From 2001 to 2007 he served as deputy director and then director of the FDA's Center for Drug Evaluation and Research.

This direct experience in regulatory affairs and public health will benefit Amgen as Galson takes over responsibility for the company's regulatory and patient safety functions.

After leaving his public health duties Galson served as VP for civilian health operations at Science Applications International Corporation until October 2010 when he joined Amgen.

14th May 2014

From: Sales, Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics